Cargando…
LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding
NFκB is a central mediator of inflammation. Present inhibitors of NFκB are mostly based on inhibition of essential machinery such as proteasome and protein kinases, or activation of nuclear receptors; as such, they are of limited therapeutic use due to severe toxicity. Here we report an LPS-induced...
Autores principales: | Lee, Hwan Hee, Sanada, Satoru, An, Seung Min, Ye, Byeong Jin, Lee, Jun Ho, Seo, Young-Kyo, Lee, Changwook, Lee-Kwon, Whaseon, Küper, Christoph, Neuhofer, Wolfgang, Choi, Soo Youn, Kwon, Hyug Moo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847014/ https://www.ncbi.nlm.nih.gov/pubmed/27118681 http://dx.doi.org/10.1038/srep24921 |
Ejemplares similares
-
Modulation of TonEBP activity by SUMO modification in response to hypertonicity
por: Kim, Jeong-Ah, et al.
Publicado: (2014) -
TonEBP suppresses IL-10-mediated immunomodulation
por: Choi, Soo Youn, et al.
Publicado: (2016) -
TonEBP suppresses adipogenesis and insulin sensitivity by blocking epigenetic transition of PPARγ2
por: Ho Lee, Jun, et al.
Publicado: (2015) -
Transcriptional Regulator TonEBP Mediates Oxidative Damages in Ischemic Kidney Injury
por: Yoo, Eun Jin, et al.
Publicado: (2019) -
Microglial TonEBP mediates LPS-induced inflammation and memory loss as transcriptional cofactor for NF-κB and AP-1
por: Jeong, Gyu Won, et al.
Publicado: (2020)